L-260-2023
Agreement ID
L-260-2023
Lead IC
NIAAA
Exclusivity
Exclusive
External Party
Inversago Pharma, Inc
Fiscal Year
2025
Territory
Worldwide
Execution Date
Effective Date
Export Date